Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04131621 |
| Title | Nivolumab/Ipilimumab in Second Line CUP-syndrome (CheCUP) |
| Acronym | CheCUP |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Hospital Heidelberg |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Heidelberg | RECRUITING | Heidelberg | Germany | Details |